Zusammenfassung
Kleinkinder mit Typ-1-Diabetes stellen aufgrund ihres niedrigen und häufig wechselnden Insulinbedarfs eine Herausforderung für den Kinderdiabetologen dar. Mittlerweile werden mehr als 80 % aller Patienten mit Typ-1-Diabetes, die jünger als 5 Jahre sind, mit einer Insulinpumpe behandelt, sodass von einer Standardtherapie für dieses Alter gesprochen werden kann. Die Insulinpumpe ermöglicht eine große Flexibilität mit Anpassung an wechselnde Bewegung, unvorhersehbare Kohlenhydrataufnahme und häufig auftretende Infektionen mit erhöhtem Insulinbedarf. Auch die Betreuung im Kindergarten und durch Pflegedienste wird durch eine Pumpe einfacher. Die Kombinationsmöglichkeit mit einer s.c.-Glukosekonzentration-Messung und einer automatischen Hypoglykämieabschaltung kann für einige Kleinkinder weitere Vorteile bieten.
Abstract
Toddlers and infants with type 1 diabetes are one of the most challenging patient groups for pediatric diabetologists because of low and frequently changing insulin requirements. In Germany more than 80 % of children less than 5 years old with type 1 diabetes are treated with an insulin pump; therefore, this is currently the standard treatment. High flexibility is essential for changing physical activity, unpredictable carbohydrate intake and frequent infectious diseases that could lead to higher insulin demand. Caregivers in kindergartens can more easily be involved in diabetes treatment with pumps. The combination of insulin pumps with continuous subcutaneous glucose measurement and an automatic low glucose switch off could have benefits for individual toddlers.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11428-012-0972-4/MediaObjects/11428_2012_972_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11428-012-0972-4/MediaObjects/11428_2012_972_Fig2_HTML.gif)
Literatur
Kapellen TM, Klinkert C, Heidtmann B et al (2010) Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for pediatric pump treatment. Postgrad Med 122:98–105
Karges B, Meissner T, Icks A et al (2011) Management of diabetes mellitus in infants. Nat Rev Endocrinol 8:201–211
Fox LA, Buckloh LM, Smith SD et al (2005) A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 28:1277–1281
Paris CA, Imperatore G, Klingensmith G et al (2009) Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatr 155:183–189
Weinzimmer SA, Ahern JH, Doyle EA et al (2004) Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 114:1601–1605
Ahern JA, Boland EA, Doane R et al (2002) Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 3:10–15
DiMeglio LA, Pottorff TM, Boyd SR et al (2004) A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 145:380–384
Litton J, Rice A, Friedman N et al (2002) Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 141:490–495
Plotnick LP, Clark LM, Brancati FL, Erlinger T (2003) Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 26:1142–1146
Wilson DM, Buckingham AB, Kunselman EL et al (2005) A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 28:15–19
Mack-Fogg JE, Orlowski CC, Jospe N (2005) Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes 6:17–21
Plank J, Siebenhofer A, Berghold A et al (2005) Systematic review and meta-analysis of short acting insulin analogues in pediatric patients with diabetes mellitus. Arch Int Med 165:1337–1344
Pankowska E, Blazik M, Dziechiarz P et al (2009) Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pediatr Diabetes 10:52–58
Jakisch B, Wagner VM, Heidtmann B et al (2008) Continuous subcutaneous insulin infusion (CSII) vs. multiple daily injections (MDI) in pediatric type 1 diabetes: a multi-center matched-pair cohort analysis over 3 years. Diabet Med 25:80–85
Kapellen TM, Wolf J, Stachow R et al (2009) Changes in the use of analogue insulins in 37206 children and adolescents with type 1 diabetes in 254 centres in Germany and Austria in the last twelve years. Exp Clin Endocrinol Diabetes 117:329–335
Klinkert C, Bachran R, Heidtmann B et al (2008) Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes 116:118–122
Bachran R, Beyer P, Klinkert C et al (2012) Basal rates and circadian profiles in continuous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes 13:1–5
Holterhus PM, Bokelmann J, Riepe F et al (2013) Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps. Diabetes Care (im Druck)
Danne T, Aman J, Schober E et al (2003) A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care 26:2359–2364
Danne T, Rastam J, Odendahl R et al (2007) Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes. Pediatr Diabetes. 8:278–285
McMahon SK, Airey FL, Marangou DA et al (2004) Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med 22:92–96
Sullivan-Bolyai S, Knafl K, Tamborlane W, Grey M (2004) Parents‘ reflections on managing their children’s diabetes with insulin pumps. J Nurs Scholarsh 36:316–323
Müller-Godeffroy E, Treichel S, Wagner V (2009) Investigation of quality of life and family burden issues during insulin pump therapy in children with type 1 diabetes mellitus – a large scale multicenter pilot study. Diabet Med 26:493–501
Yeh HC, Brown TT, Maruthur N et al (2012) Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and metaanalysis. Ann Intern Med 157:336–347
Battelino T, Conget I, Olsen B et al (2012) The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55:3155–3162
Ly TT, Nicholas JA, Retterath A et al (2012) Analysis of glucose respond to automated insulin suspension with sensor augmented pump therapy. Diabetes Care 35:1462–1465
Danne T, Kordonouri O, Holder M et al (2011) Prevention of hypoglycaemia by using low glucose suspend function in sensor augmented pump therapy. Diabetes Technol Ther 13:1129–1134
Interessenkonflikt
Der korrespondierende Autor weist für sich und seine Koautoren auf folgende Beziehungen hin: T. Kapellen bekam Vortragshonorare von den Firmen Medtronic, Roche und Lilly.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kapellen, T., Heidtmann, B., Holl, R. et al. Insulinpumpentherapie. Diabetologe 9, 135–139 (2013). https://doi.org/10.1007/s11428-012-0972-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-012-0972-4